Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07BXE
|
||||
Former ID |
DIB005578
|
||||
Drug Name |
Daniquidone
|
||||
Synonyms |
Batracylin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] | Phase 1 | [521991] | ||
Company |
National Cancer Institute
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H11N3O
|
||||
Canonical SMILES |
C12=Nc3c(CN1C(=O)c1c2cccc1)cc(cc3)N
|
||||
CAS Number |
CAS 67199-66-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Toposisomerase-1 | Target Info | Modulator | ||
DNA topoisomerase II | Target Info | Modulator | |||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | DNA replication | ||||
Pathway Interaction Database | Caspase Cascade in Apoptosis | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.